Par-4 Downregulation Promotes Breast Cancer Recurrence by Preventing Multinucleation following Targeted Therapy
2013 · Cancer Cell · 120 citations
https://doi.org/10.1016/j.ccr.2013.05.007
Y
Yi Feng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
136
Papers
4.2K
Citations
34
h-index
66
i10-index
Yi Feng is an academic researcher from Guizhou Academy of Agricultural Sciences. The author has contributed to research in topics: Clinical Nutrition and Gastroenterology & Cancer-related molecular mechanisms research & Nanoplatforms for cancer theranostics. The author has an h-index of 34, co-authored 116 publications.
ORCID: 0000-0003-1493-1968Papers by this author
worksEfficacy and safety of corticosteroids, hyaluronic acid, and PRP and combination therapy for knee osteoarthritis: a systematic review and network meta-analysis
2023 · BMC Musculoskeletal Disorders · 59 citations
https://doi.org/10.1186/s12891-023-06925-6
Remodeling tumor immunosuppressive microenvironment via a novel bioactive nanovaccines potentiates the efficacy of cancer immunotherapy
2022 · Bioactive Materials · 52 citations
https://doi.org/10.1016/j.bioactmat.2022.03.008
Cascade-activatable NO release based on GSH-detonated “nanobomb” for multi-pathways cancer therapy
2022 · Materials Today Bio · 48 citations
https://doi.org/10.1016/j.mtbio.2022.100288
Obesity-Induced Insulin Resistance Is Mediated by High Uric Acid in Obese Children and Adolescents
2021 · Frontiers in Endocrinology · 38 citations
https://doi.org/10.3389/fendo.2021.773820
A versatile nanoplatform for synergistic chemo-photothermal therapy and multimodal imaging against breast cancer
2020 · Expert Opinion on Drug Delivery · 32 citations
https://doi.org/10.1080/17425247.2020.1736033
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat